Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis
Cancer Medicine · 2025
DOI: 10.1002/cam4.71194 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Cayleigh de Sousa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa. Hauptthemen laut MEDLINE: Resveratrol, Uterine Cervical Neoplasms, Carboplatin, Hyaluronan Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of South Africa, South African Medical Research Council, Technology Innovation Agency.
Abstract (Originalsprache)
Background
Cervical cancer remains a leading cause of cancer‐related mortality among women globally. Persistent infection with high‐risk human papillomavirus drives cervical carcinogenesis, and treatment outcomes are frequently challenged by metastasis and chemoresistance. The transmembrane glycoprotein cluster of differentiation 44 (CD44), a marker associated with cancer stem cells (CSCs), has emerged as a critical mediator of both processes in cervical cancer.
Objective
This review aims to critically evaluate current evidence on the role of CD44 in cervical cancer progression, metastasis, and treatment resistance. It also explores the potential of resveratrol, a naturally occurring polyphenol with known anticancer properties, as a chemo‐sensitizing agent to carboplatin therapy.
Methods
A comprehensive review of the literature was conducted using databases such as PubMed, Google Scholar, and Scopus to identify studies that investigate CD44‐mediated mechanisms in cervical cancer, as well as the modulatory and mechanistic effects of resveratrol on CD44 and chemoresistance across various cancer types.
Results
CD44 has been consistently implicated in promoting drug resistance, epithelial‐to‐mesenchymal transition (EMT), and stemness in cervical cancer. Resveratrol has demonstrated antimetastatic and chemo‐sensitizing effects in several malignancies, such as colorectal and breast cancers, often through modulation of CD44 and associated pathways. However, direct evidence in cervical cancer remains limited.
Conclusion
Current findings suggest a promising therapeutic avenue for combining resveratrol with carboplatin to overcome CD44‐mediated treatment resistance and metastasis in cervical cancer. Nonetheless, further cervical‐specific studies are needed to validate this approach. A clearer understanding of this relationship may facilitate lower chemotherapy dosing, reduced toxicity, and improved clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.
ORCID-Profile: Cayleigh de Sousa, Carla Eksteen, Anna-Mart Engelbrecht
Förderung
- National Research Foundation of South Africa
- South African Medical Research Council
- Technology Innovation Agency
- Cancer Association of South Africa
Zitieren
APA
de Sousa, C., Eksteen, C., & Engelbrecht, A. M. (2025). Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis. Cancer Medicine. https://doi.org/10.1002/cam4.71194
Vancouver
de Sousa C, Eksteen C, Engelbrecht AM. Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis. Cancer Medicine. 2025. doi:10.1002/cam4.71194
BibTeX
@article{deSousa2025,
author = {de Sousa, Cayleigh and Eksteen, Carla and Engelbrecht, Anna-Mart},
title = {Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71194}
}
EUVIMED